Bank of Nova Scotia
MRNA icon

Bank of Nova Scotia’s Moderna MRNA Stock Holding History

Bank of Nova Scotia’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-471
Closed -$13.4K – 1077
2025
Q1 		$13.4K Hold
471
– – ﹤0.01% 1037
2024
Q4 		$19.6K Hold
471
– – ﹤0.01% 1037
2024
Q3 		$31.5K Hold
471
– – ﹤0.01% 985
2024
Q2 		$55.9K Buy
+471
New +$59.6K ﹤0.01% 970

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of Nova Scotia's MRNA Position: Q2 2026 in Review

Bank of Nova Scotia reduced its Moderna (MRNA) stake by 0.62% in Q2 2026, selling an estimated $2.48K and leaving 7,735 shares worth $542K. The position accounts for ﹤0.01% of the portfolio, ranked #932.

Bank of Nova Scotia first reported a position in MRNA in Q2 2020 and has held it in 25 quarters since. The position peaked at $61.8M in Q4 2021. 542 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Bank of Nova Scotia held 7,735 shares of Moderna worth $542K as of Q2 2026.
  • Bank of Nova Scotia sold 48 Moderna shares in Q2 2026, an estimated $2.48K.
  • Moderna made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q2 2026, its #932 holding.
  • Bank of Nova Scotia first reported a position in Moderna in Q2 2020 and has held it in 25 quarters since.
  • Bank of Nova Scotia's Moderna position peaked at $61.8M in Q4 2021.
  • 542 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.